help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Strandjord, T. P.
Right arrow Articles by Clark, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Strandjord, T. P.
Right arrow Articles by Clark, J. G.

Am. J. Respir. Cell Mol. Biol., Vol 13, No. 3, 09 1995, 279-287.

SPARC participates in the branching morphogenesis of developing fetal rat lung

TP Strandjord, EH Sage and JG Clark
Department of Pediatrics, University of Washington, Seattle 98195-6320, USA.

Adhesion of cells to components of the extracellular matrix has been shown to be critical in normal lung development, particularly during the pseudoglandular stage, when conducting airways are forming through a process of branching morphogenesis. Expression of factors that inhibit cellular adhesion might also modulate branching morphogenesis. SPARC is a secreted glycoprotein that exhibits antiadhesive effects on cultured cells and is widely expressed in embryonic tissues. In this report, we examine the distribution of SPARC in fetal rat lung during development and its effect on the process of branching morphogenesis. Immunohistochemistry and in situ hybridization studies revealed that SPARC was present in the airway epithelial cells during the pseudoglandular stage of lung development, and in blood vessels and smooth muscle cells associated with airways during the canalicular and saccular stages of development. We used an in vitro model of rat lung branching morphogenesis to examine airway branching in the presence of: a) a neutralizing anti-SPARC antibody; or b) a synthetic peptide from a region of SPARC that, like the native protein, perturbs cell adhesion and diminishes the synthesis of fibronectin and thrombospondin 1. Lungs cultured in the presence of either reagent exhibited diminished branching and an abnormal morphology that was characterized in part by dilated airways. These findings implicate SPARC in the development of the airways.


This article has been cited by other articles:


Home page
HeartHome page
A Charest, A Pepin, R Shetty, C Cote, P Voisine, F Dagenais, P Pibarot, and P Mathieu
Distribution of SPARC during neovascularisation of degenerative aortic stenosis
Heart, December 1, 2006; 92(12): 1844 - 1849.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
D. K. Madtes, A. L. Elston, L. A. Kaback, and J. G. Clark
Selective Induction of Tissue Inhibitor of Metalloproteinase-1 in Bleomycin-Induced Pulmonary Fibrosis
Am. J. Respir. Cell Mol. Biol., May 1, 2001; 24(5): 599 - 607.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
R. Thomas, L. D. True, J. A. Bassuk, P. H. Lange, and R. L. Vessella
Differential Expression of Osteonectin/SPARC during Human Prostate Cancer Progression
Clin. Cancer Res., March 1, 2000; 6(3): 1140 - 1149.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
T. P. Strandjord, D. K. Madtes, D. J. Weiss, and E. H. Sage
Collagen accumulation is decreased in SPARC-null mice with bleomycin-induced pulmonary fibrosis
Am J Physiol Lung Cell Mol Physiol, September 1, 1999; 277(3): L628 - L635.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 1995 American Thoracic Society.